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Much more than the sum of the parts: structures of the 
dual SH2 domains of ZAP-70 and Syp 
Proteins involved in signaling pathways frequently contain one or more SH2 domains. New 
structural information on proteins that carry two SH2 domains show, surprisingly, that the 
domains are closely interlinked, so the binding sites are rigidly oriented with respect to each 
other. Thus, only ligands with the right spacing of the phosphotyrosines will be tightly bound. 
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One of the major challenges in the investigation of intra- 
cellular signal transduction is unraveling the interactions of 
the multiple targeting domains in pathways. In signaling 
involving phosphotyrosine, the kinases (adding phosphate 
from ATP to the tyrosine oxygen), and phosphatases 
(removing the phosphate from phosphotyrosine) contain 
other domains in addition to the catalytic one.The four 
kinds of additional domains now generally recognized, Src 
homology 2 and 3 (SH2, SH3), the ‘alternate’ phospho- 
tyrosine binding domain (PTB), and the pleckstrin 
homology domain (PH) [ 1,2], can frequently be expressed 
as individual domains that have similar properties to those 
in the full length protein. Many of the enzymes and 
adaptor proteins (proteins that lack specific enzymatic 
activity) involved in signal transduction also have sites for 
phosphorylation that presumably bind inter- or intra- 
molecularly to SH2 and/or PTB domains, and proline- 
rich segments that similarly bind to SH3 domains. This 
rich complexity rapidly leads to a problem of identifying 
physiologically significant interactions, especially since the 
variability in binding affinities among the individual 
domain types are relatively modest, of two to three orders 
of magnitude [3]. One way of resolving this problem of 
modest specificity, and defining what really interacts with 
what, is to use the combined specificities of more than 
one of the domains to achieve significantly greater speci- 
ficity, expanding a lock-and-key recognition system to two 
(or more) locks and keys. 
Two recently published structures of dual SH2 domains 
elegantly illustrate this point, and show some new features 
of such interactions that had not previously been clearly 
described, specifically the topological orientation of the 
domains, and the role of ‘tied’, or independent ligands. 
One structure is of the dual SH2 domains of ZAP-70 
(zeta-associated protein of 70 kDa) kinase in a complex 
with a doubly-phosphorylated peptide, the immuno- 
receptor tyrosine-mediated activation motif (ITAM), 
derived from the zeta (5) subunit of the T-cell receptor 
[4]. The ZAP-70 kinase binds to the ITAMs of the T-cell 
receptor after they have been phosphorylated by a 
member of the Src family of tyrosine kinases, and its 
activity is required for T-cell activation [5]. The other 
structure is of the dual SH2 domains from the phos- 
phatase SH-PTP2 (also known as Syp, PTP2C and 
PTPlD), with the two SH2 domains occupied by an 
1 l-residue phosphopeptide derived from the platelet- 
derived growth factor receptor (PDGFR) [6]. The 
observed independence of SH2 and SH3 domains in Lck 
[7], Grb2 [S], and Abl [9] suggested that multiple SH2 
domains in one protein might be relatively independent. 
The two new structures show, however, that these dual 
SH2 domains are in fact tightly interrelated. 
ZAP-70 dual SH2 domains 
In the ZAP-70 structure ([4]; Fig. l), the carboxy-terminal 
SH2 domain is readily recognizable, having the features 
expected for a single SH2 domain - a well-defined deep 
binding pocket for the phosphotyrosyl side chain, a sec- 
ondary ‘plug’ site for specific hydrophobic interactions 
with the ligand, carboxy-terminal to the phosphotyrosine, 
and a compact fold. The carboxy- and amino-terminal 
SH2 domains are linked by a long (65 amino acid) ‘inter- 
domain’, which is highly structured, forming a coiled coil. 
The amino and carboxyl termini of the interdomain are 
close, bringing the amino- and carboxy-terminal SH2 
domains into contact. The amino-terminal SH2 domain 
differs significantly from the expected structure for an 
SH2 domain, however. Most surprisingly, the normally 
well defined charge and hydrogen bond arrangement 
around the phosphotyrosine that binds to the amino- 
terminal SH2 is significantly different from that seen 
before. As usual, the phosphotyrosyl side chain is well 
buried in the protein, but its contacts are provided by both 
amino- and carboxy-terminal SH2 domains. The relevant 
residues from the carboxy-terminal SH2 domain are from 
the carboxy-terminal helix ((YB; [7]), which has not previ- 
ously been implicated in phosphotyrosine binding. 
Curiously, this well-defined interface may not exist in the 
absence of the ITAM ligand, since, prior to the addition of 
ligand, the uncomplexed dual SH2 domains of ZAP-70 
apparently exist in multiple conformations based on iso- 
electric focusing [4]. Part of the entropic cost for this 
alignment on binding may come from the binding of the 
‘intermotif’ of the ligand (NLGRREE; Fig. l), which 
forms a nearly complete o-helical turn and makes multi- 
ple hydrogen bonds and charge-mediated contacts to the 
protein, in a fashion not previously observed in SH2 struc- 
tures.The thermodynamic contribution of this interaction 
remains to be identified. 
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Antigen presenting cell 
Fig. 1. Cartoon of ZAP-70 bound to the 
phosphorylated 5, subunit of the acti- 
vated T-cell receptor. Left, the T-cell 
receptor binds to a complex of anti- 
gen and the major histocompatibility 
complex (MHC) present on an antigen 
presenting cell. This association stimu- 
lates phosphorylation of theT-cell recep- 
tor on tyrosine residues (red) within 
the ITAMs (immunoreceptor tyrosine- 
mediated activation motif). The SH2 
domains of ZAP-70 bind to the phos- 
phorylated ITAMs. Right, a schematic of 
the doubly-phosphorylated 5, ITAM 
bound to ZAP-70, based on the 
observed crystal structure. The structure 
of the catalytic domain and inter- 
domain B of ZAP-70 have not yet been 
determined; these domains are shown in 
a lighter grey. The phosphotyrosine (red) 
and two leucine residues (yellow) are 
the principal specificity determinants. 
Reprinted with permission from [4]. 
The ZAP-70 SH2 domains give a clear indication that 
SH2 domain-ligand interactions can be very different 
from those seen in the examples previously known [lo], 
and that some interactions are modulated by neighbor- 
ing domains. Recognition of the ITAM ligand appar- 
ently requires two co-linear phosphotyrosine sites on 
the ligand (orientation I, Fig. 2) with a spacing that is 
complemented by the fixed, short separation of the 
binding sites in the complex. 
SH-PTP2 
The similarity of the structure of the dual SH2 domains 
of SH-PTP2 [6] to those previously determined for 
single SH2 domains can be summed up by the observa- 
tion that the dual domain structure could be solved 
using molecular replacement with the previously deter- 
mined single SH2 domain [ 111. The two domains super- 
impose (with ligand bound) to a root-mean-square 
deviation value of 0.56 A. There are small systematic 
differences between the two domains, in particular a 
rotation of one of the phosphates around the C-O bond 
of the phosphotyrosine, leading to a different network of 
hydrogen bonds to the phosphate. Otherwise the ligand 
interactions are very similar to the single domain 
complex [l 11. Of particular note is the nature of the 
interface, and the constraints that this then imposes on 
the orientation of the binding sites.The crystal structure 
contains an intramolecular cystine link, even though the 
crystals were grown in solutions containing 10 mM 
dithiothreitol, pH 8.5. The authors note that cystine 
bridges are uncommon in cytoplasmic proteins. The 
view that this bridge would exist normally in the intact 
mammalian protein (the protein was expressed in 
Ercherichia coli) is most strongly supported by the tight 
packing of residues around it in the interdomain inter- 
face, and the mean temperature factor of this region, 
which indicates that it is as well ordered as the rest of 
the protein. 
Many of the phosphotyrosine phosphatases contain SH2 
domains, and it is has often been suggested that the inter- 
action between the SH2 domains and phosphotyrosines 
on the ligand may protect those residues leading to a 
selective pattern of remaining phosphotyrosines while 
other sites are dephosphorylated. The occupancy of the 
SH2 domains also apparently increases the enzymatic 
activity of the phosphatase. In the case of SH-PTP2,the 
inhibitory effects of the SH2 domains are not mediated 
by intramolecular binding to phosphorylation sites on 
SH-PTP2 itself, as protein from E. cd, which is presum- 
ably not post-translationally modified, still shows the inhi- 
bition effect [12,13]. The view of the dual domains of 
SH-PTP2 does not offer any obvious clues as to how 
activation (disinhibition) might proceed, although the 
tight interaction between the dual SH2 domains raises the 
possibility that they might move as a single unit. 
The two SH2 sites for phosphopeptides in SH-PTP2 
[6] are occupied in the structure by two molecules of 
the same ligand (Fig. 3). It is observed ]6] that in syn- 
thetic ligands with two phosphotyrosyl motifs, the 
topology and the separation of the two motifs critically 
affects the level of activation of SH-PTP2 enzymatic 
activity. The maximally effective activator has an 
expected distance, for an extended chain, of about 41 A 
between the phosphotyrosines, closely matching the 
crystallographically determined distance between the 
two phosphotyrosines (of individual ligands) in the 
structure of the dual SH2 domains. 
As with ZAP-70, the binding sites are on one face of the 
protein. In contrast to the colinear ensemble (Fig. 2, ori- 
entation I) of ZAP-70, the sites in SH-PTP2 are more 
nearly antiparallel to each other (Fig. 2, orientationV1). 
Figure 2 compares the binding orientations observed or 
expected for domains facing in the same direction. 
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ZAP-70 
SH-PTP2 
Fig. 2. Possible orientations of ligands bound to dual SH2 
domains. I: Colinear orientation, with a bis-epitopic ligand occu- 
pying both sites and an inter-ligand linker between them, as seen 
in the ZAP-70 structure [4]. II, III: Two other colinear orientations. 
IV: Parallel orientation. V: antiparallel orientation. VI: approximate 
orientation in SH-PTP2 [6]. 
Orientation I is superficially the simplest for dual 
domains binding to a ligand with two epitopes, in that 
the linker between the two binding sites of the ligand is 
shorter than any other. The shorter the interdomain 
linker, the lower the likelihood that two domains from 
separate molecules might recognize the signal ligand. Of 
course, things are rarely so simple, as evidenced by the 
varied grouping of phosphotyrosines in other proteins, 
and the helical inter-ligand linker observed in ZAP-70. 
When recognizing ligands that are close together but not 
colinear several other arrangements are possible. Ligands 
may be clustered by, for example, their presence in the 
carboxyl-termini of dimerized growth factor receptors. 
In this case, the C, symmetry of the dual ligand might be 
Fig. 3. GRASP [18] surface of the 
tandem SH2 domains of SH-PTP2 with 
bound peptides shown in stick repre- 
sentation. The phosphopeptides are 
widely spaced and in a roughly anti- 
parallel orientation; the two domains 
have a substantial interface between 
them. Reprinted with permission from [6]. 
reflected in the pseudo-C1 symmetry of orientations II, 
III,V andV1 of Figure 2. Of these, orientations II and III 
would require fairly close contact between the ends of 
the ligands. Orientation V, similar to that seen for 
SH-PTP2 (VI) requires the least ligand-ligand contacts. 
Can we rationalize why both ZAP-70 and SH-PTP2 
have both SH2 binding sites on one side of the respective 
proteins? One clue may be that interest in the specific 
recognition sites has distracted attention from the likeli- 
hood that intracellular signaling complexes involve very 
many protein-protein (and possibly other) interactions, 
and therefore all the other faces of the dual domains may 
be occupied. Such ‘large complex’ models would gener- 
ally require that coordinated interaction of dual domains 
use a common face. 
Therapeutic directions 
ZAP-70 is a target for intervention to block pathologic 
T-cell activation in autoimmune disease, or to immuno- 
suppress generally. Phosphatase-resistant ITAM analogs 
can block ZAP-70 association with the activated recep- 
tor in permeabilized cells [14] (and reported in [15]). 
While it may be difficult to find cell-permeable phos- 
photyrosine analogs, the ZAP-70 structure may permit 
design of other peptidomimetics by mimicking the 
ITAM binding augmented by other contacts, such as 
those of the ‘intermotif’. Alternatively, the unusual 
amino- and carboxy-terminal SH2 interface might 
be blocked to prevent the formation of the second 
phosphotyrosine binding pocket. 
SH-PTP2 is not itself a current target for therapeutic 
intervention, but it serves as an important model for 
phosphatases, which are likely to be. For example, there 
is increased interest [16] in gene products whose expres- 
sion is necessary, but not sufficient, for malignant trans- 
formation. Phosphatases are part of the critical series of 
‘on-off’ switches controlling progression through the 
cell cycle, and phosphatase inhibitors are effective 
inducers at the mitotic entry checkpoint 1171. Effecters 
based on dual occupancy of the SH2 domains of the 
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dual SH2 phosphatases may be significant reagents for 
investigational and therapeutic research in these areas. 
In conclusion, these two structures and their compari- 
son significantly extend our views of how SH2 domains 
are involved in signaling processes and what the role of 
multivalent ligands may be. 
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